These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

926 related items for PubMed ID: 10086151

  • 1. [Drug therapy in Parkinson's disease].
    van Hilten JJ, Roos RA.
    Ned Tijdschr Geneeskd; 1999 Jan 30; 143(5):234-40. PubMed ID: 10086151
    [Abstract] [Full Text] [Related]

  • 2. Basic research on dopamine in Parkinson's disease and the discovery of the nigrostriatal dopamine pathway: the view of an eyewitness.
    Hornykiewicz O.
    Neurodegener Dis; 2008 Jan 30; 5(3-4):114-7. PubMed ID: 18322366
    [Abstract] [Full Text] [Related]

  • 3. Treatment options for early Parkinson's disease.
    Stacy M, Brownlee HJ.
    Am Fam Physician; 1996 Mar 30; 53(4):1281-7. PubMed ID: 8629572
    [Abstract] [Full Text] [Related]

  • 4. Initial therapy for Parkinson's disease: levodopa vs. dopamine receptor agonists.
    Kondo T.
    J Neurol; 2002 Sep 30; 249 Suppl 2():II25-9. PubMed ID: 12375060
    [Abstract] [Full Text] [Related]

  • 5. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
    Prescott IA, Dostrovsky JO, Moro E, Hodaie M, Lozano AM, Hutchison WD.
    Brain; 2009 Feb 30; 132(Pt 2):309-18. PubMed ID: 19050033
    [Abstract] [Full Text] [Related]

  • 6. [Are dopamine agonists alternative therapy for levodopa in early stage of Parkinson's disease? No].
    Friedman A.
    Neurol Neurochir Pol; 2007 Feb 30; 41(2 Suppl 1):S10-3. PubMed ID: 17941453
    [Abstract] [Full Text] [Related]

  • 7. [Medicinal treatment of idiopathic Parkinson's disease].
    Klockgether T.
    Nervenarzt; 2003 Mar 30; 74 Suppl 1():S12-21. PubMed ID: 12624679
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The history of dopamine and levodopa in the treatment of Parkinson's disease.
    Fahn S.
    Mov Disord; 2008 Mar 30; 23 Suppl 3():S497-508. PubMed ID: 18781671
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Parkinson's disease.
    Barboi AC, Goetz CG.
    Clin Neuropharmacol; 1999 Mar 30; 22(4):184-91. PubMed ID: 10442246
    [No Abstract] [Full Text] [Related]

  • 12. Treatment strategies in Parkinson's disease after a quarter century experiences with L-DOPA therapy.
    Fischer PA.
    J Neural Transm Suppl; 1995 Mar 30; 46():381-9. PubMed ID: 8821073
    [Abstract] [Full Text] [Related]

  • 13. Treatment of Parkinson's disease.
    Hely MA, Fung VS, Morris JG.
    J Clin Neurosci; 2000 Nov 30; 7(6):484-94. PubMed ID: 11029227
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Parkinson's disease: the case for novel treatment strategies.
    Stern MB, Freese A.
    Exp Neurol; 1997 Mar 30; 144(1):2-3. PubMed ID: 9126142
    [Abstract] [Full Text] [Related]

  • 16. Drugs for Parkinson's disease.
    Treat Guidel Med Lett; 2013 Nov 30; 11(135):101-6. PubMed ID: 24165688
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dopaminergic agonists in the treatment of Parkinson's disease: a review.
    Piccoli F, Riuggeri RM.
    J Neural Transm Suppl; 1995 Nov 30; 45():187-95. PubMed ID: 8748625
    [Abstract] [Full Text] [Related]

  • 19. [Problems and future perspectives in the treatment of Parkinson's disease].
    Hens L, Hellemans J.
    Tijdschr Gerontol Geriatr; 1982 Aug 30; 13(4):147-54. PubMed ID: 6127822
    [Abstract] [Full Text] [Related]

  • 20. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
    Talati R, Baker WL, Patel AA, Reinhart K, Coleman CI.
    Int J Clin Pract; 2009 Apr 30; 63(4):613-23. PubMed ID: 19222614
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.